The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery
RIPC
1 other identifier
interventional
1,200
1 country
1
Brief Summary
Perioperative myocardial injury is a serious complication of cardiac surgery. This complication increases both mortality and morbidity of cardiac surgery. Remote ischemic preconditioning (RIPC) is the concept that brief ischemia followed by reperfusion in an organ can reduce subsequent ischemia-reperfusion injury in distant organs. Recent several clinical trials showed powerful myocardial protective effect of remote ischemic preconditioning by reducing postoperative cardiac enzymes. However, the evidence that remote ischemic preconditioning can improve the clinical outcomes such as mortality and morbidity, is still lacking. The investigators perform a multicenter randomized controlled study to evaluate that remote ischemic preconditioning can improve the outcomes of cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Oct 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 15, 2009
CompletedFirst Posted
Study publicly available on registry
October 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedFebruary 24, 2011
February 1, 2011
11 months
October 15, 2009
February 22, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
In-hospital death
Postoperative 30 days
Myocardial infarction
Postoperative 30 days
Stroke
Postoperative 30 days
Respiratory failure
Postoperative 30 days
Renal dysfunction
Postoperative 30 days
Renal failure
Postoperative 30 days
Cardiogenic shock
Postoperative 30 days
Gastrointestinal complication
Postoperative 30 days
Secondary Outcomes (2)
Length of ICU stay
Postoperative 3 months
Length of postoperative hospital stay
Postoperative 3 months
Interventions
remote ischemic preconditioning (4 x 5 min upper limb ischemia with pneumatic cuff up to 200 mmHg with an intervening 5 min reperfusion; 2 cycles; before and after the coronary anastomosis or cardiopulmonary bypass)
Eligibility Criteria
You may qualify if:
- adult patients undergoing cardiac surgery
You may not qualify if:
- emergent operation
- preoperative use of inotropics or mechanical assist device,
- left ventricular ejection fraction less than 30%,
- severe liver, renal and pulmonary disease,
- recent myocardial infarction (within 7 days),
- recent systemic infection or sepsis (within 7 days)
- peripheral vascular disease affecting upper limbs
- amputation of the upper limbs
- major combined operation such as aortic surgery or carotid endarterectomy
- descending thoracic aortic surgery
- rare surgeries; cardiac transplantation, correction of complicated congenital anomalies, pulmonary thromboembolectomy, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Asan Medical Centercollaborator
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
Related Publications (2)
Cho YJ, Lee EH, Lee K, Kim TK, Hong DM, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery. Int J Cardiol. 2017 Mar 15;231:84-89. doi: 10.1016/j.ijcard.2016.12.146. Epub 2016 Dec 23.
PMID: 28043669DERIVEDHong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014 Jan;35(3):176-83. doi: 10.1093/eurheartj/eht346. Epub 2013 Sep 7.
PMID: 24014392DERIVED
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
YunSeok Jeon, professor
Department of Anesthesiology and Pain Medicine, SNUH
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 15, 2009
First Posted
October 19, 2009
Study Start
October 1, 2009
Primary Completion
September 1, 2010
Study Completion
November 1, 2010
Last Updated
February 24, 2011
Record last verified: 2011-02